Articles, guides, and updates from our team.
A drug company leader recently called muscle loss on GLP 1 no crisis at all. For adults over 50 with less muscle to spare, the honest answer sits in your scan numbers. Here is how a DEXASCAN scan and a physician read of fat, muscle, and visceral fat turn a headline into a plan you can prove is working.
Zyndio and DEXASCAN have announced a collaboration to develop From Scan to Plan, a proposed model connecting DEXA body composition measurement with physician led care. Here is what it means, why the scale was never the right scoreboard, and what it changes for anyone on GLP 1.
Your appetite gets quiet on GLP 1, but your muscle still needs protein every single day. Here is a clear daily target for adults over 50, how to divide it across meals when you are barely hungry, and how a physician can tell if your plan is protecting your muscle.
A DEXA scan gives you the most honest numbers in health: visceral fat, lean mass, and bone density, measured with real precision. But a scan is a snapshot. Here is what should happen next, and why the plan built on the scan matters more than the scan itself.
One of the first questions people ask before starting GLP 1 treatment: do I have to stay on this forever? Here is the honest answer, what the research shows about stopping, and what long term care actually looks like.
Wondering what actually happens at a first appointment for weight loss medication? Here is the full walk through, from health history and labs to your personalized plan, so you know exactly what to expect.
Your scale says you lost 30 pounds. It cannot tell you how much was muscle. Here is why a DEXA scan changes the whole picture on GLP 1, and what to do with what it shows.
GLP-1 medications are titrated slowly for a reason. Here is the pharmacological rationale, the standard escalation schedules for semaglutide and tirzepatide, and what to expect at each step.
Compounded semaglutide and tirzepatide differ from branded GLP-1s in regulation, sourcing, and FDA status. Here's what patients need to know.
GLP-1 receptor agonists like semaglutide and tirzepatide can cause nausea, constipation, and other GI side effects. Here's how to manage them.
